GlassScriptPhysician profile
Danielle Spillane Johnston
NPI 1245708387
$3,176.72
in general payments reported to CMS, 2019-2025
14 companies · $2,334 in 2025
The $2,334 reported for 2025 was more than what 96% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $98.71 · 2023: $349 · 2024: $395 · 2025: $2,334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,573 · Travel and Lodging: $1,505.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,573.21 |
| Travel and Lodging | $1,504.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,052.52 | 2025 | Cardiomems |
| Merck Sharp & Dohme LLC | $289.79 | 2022-2025 | Verquvo, Capvaxive |
| Boehringer Ingelheim Pharmaceuticals, INC. | $229.65 | 2022-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $172.01 | 2022-2025 | Lifevest |
| Actelion Pharmaceuticals US, INC. | $114.62 | 2023 | Uptravi, Opsumit |
| Bayer Healthcare Pharmaceuticals INC. | $66.98 | 2025 | |
| Boston Scientific Corporation | $49.00 | 2022-2024 | Resonate El Icd Vr |
| Astrazeneca Pharmaceuticals LP | $47.14 | 2022-2024 | Farxiga |
| Novartis Pharmaceuticals Corporation | $38.29 | 2022-2023 | |
| Scpharmaceuticals INC. | $29.18 | 2024 | |
| Sanofi Pasteur INC. | $26.48 | 2024 | |
| Lexicon Pharmaceuticals, INC. | $24.19 | 2023 | Inpefa |
| Cvrx, INC. | $22.62 | 2025 | Barostim Neo System |
| Novo Nordisk INC | $14.25 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Johnston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.